Sivis's trading volume on March 13th was $347 million, a decrease of 41.31% compared to the previous trading day.

On March 13, 2026, drug retail company CVS recorded a trade value of $347 million, ranking 336th among U.S. stocks that day. The trade value decreased by 41.31% from the previous day, and the trading volume for the day was 4.5376 million.

CVS (CVS) rose 0.08% on March 13, 2026, to $76.13. The stock has fallen 2.30% over the past 5 trading days, down 4.72% for the entire month of March, down 4.07% since the beginning of the year, and up 15.79% over the past 52 weeks.

If the company has been listed for fewer than 52 weeks, the 52-week gain/loss is calculated as the gain/loss from the listing date to now (the same applies to listings for fewer than 1 month or fewer than 5 trading days).

CVS Health Corporation was incorporated in 1996 in Delaware. It is a leading health solutions company that provides services to consumers through an integrated model that connects healthcare and pharmacy services across the United States. The company operates retail locations, walk-in and primary care medical clinics, and pharmacy benefit management businesses that serve millions of members. CVS Health also offers health insurance products and related services, including Medicare Advantage and Medicare Part D prescription drug plans. Through its comprehensive approach, the company focuses on expanding the delivery of personalized, technology-driven care and health services to improve access to quality care, enhance health outcomes, and reduce overall healthcare costs. CVS Health operates through four reportable operating segments: Healthcare Benefits, Health Services, Pharmacy and Consumer Health, and Corporate.